Danggui Sini decoction protects against oxaliplatin-induced peripheral neuropathy in rats

Danggui Sini decoction protects against oxaliplatin-induced peripheral neuropathy in rats

The effects of Danggui Sini decoction on peripheral neuropathy in oxaliplatin-induced peripheral is established. The results indicated that Danggui Sini decoction treatment significantly reduced the current amplitude of dorsal root ganglia cells undergoing agonists stimuli compared to the model-dors...

Full description

Bibliographic Details
Main Authors:	Rong Ding, Yue Wang, Ji-Ping Zhu, Wu-Guang Lu, Guo-Li Wei, Zhan-Cheng Gu, Zhen-Tao An, Jie-Ge Huo
Format:	Article
Language:	English
Published:	IMR (Innovative Medical Research) Press Limited 2020-12-01
Series:	Journal of Integrative Neuroscience
Subjects:	oxaliplatin peripheral neuropathy neurotoxicity electrophysiology
Online Access:	https://jin.imrpress.com/fileup/1757-448X/PDF/1609231251596-467254597.pdf

Similar Items

Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2021-07-01)

Metformin protects from oxaliplatin induced peripheral neuropathy in rats
by: N.W. Martinez, et al.
Published: (2020-08-01)

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats
by: Lee Jung, et al.
Published: (2012-08-01)

Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice
by: Dorsey Susan G, et al.
Published: (2011-04-01)

Oxaliplatin-Induced Peripheral Neuropathy Grade in Females with Colorectal Cancer Patients
by: Inas Moawya Ahmed, et al.
Published: (2019-06-01)

Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
by: Andreas A. Argyriou
Published: (2015-05-01)

Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy
by: Guido Cavaletti, et al.
Published: (2020-05-01)

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
by: Riccardo Giampieri, et al.
Published: (2019-12-01)

Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
by: Takehiro Kawashiri, et al.
Published: (2021-01-01)

Herbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients
by: Xiaolan Cheng, et al.
Published: (2017-06-01)

Ibudilast suppresses oxaliplatin-induced mechanical allodynia and neurodegeneration in rats
by: Nobuaki Egashira, et al.
Published: (2021-09-01)

Quantitative detection of targeted neurotransmitters in dorsal root ganglia in rats with chronic peripheral neurotoxicity caused by oxaliplatin
by: ZHENG Wenling, et al.
Published: (2020-04-01)

Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy
by: Jordi Bruna, et al.
Published: (2018-01-01)

Formononetin ameliorates oxaliplatin-induced peripheral neuropathy via the KEAP1-NRF2-GSTP1 axis
by: Yuan Fang, et al.
Published: (2020-09-01)

Neuroprotective Effects of an Aqueous Extract of <i>Forsythia viridissima</i> and Its Major Constituents on Oxaliplatin-Induced Peripheral Neuropathy
by: Jin-Mu Yi, et al.
Published: (2019-03-01)

Axonal Transport Impairment in Chemotherapy-Induced Peripheral Neuropathy
by: Gabriella Nicolini, et al.
Published: (2015-08-01)

Managing treatment-related peripheral neuropathy in patients with multiple myeloma
by: Grammatico S, et al.
Published: (2016-06-01)

Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review
by: Nedal Bukhari, et al.
Published: (2017-06-01)

Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth
by: Olivier Cerles, et al.
Published: (2019-01-01)

Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study
by: Tsuruta A, et al.
Published: (2016-11-01)

Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial
by: Balayssac, D., et al.
Published: (2022)

The Incidence of Oxaliplatin-Induced Peripheral Neurotoxicity at Khartoum Oncology Hospital: A Cross-Sectional Survey
by: Nadeen T Ali, et al.
Published: (2020-01-01)

The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)
by: Hiroaki Tanioka, et al.
Published: (2019-10-01)

Antioxidant Supplementation in the Treatment of Neurotoxicity Induced by Platinum-Based Chemotherapeutics—A Review
by: Jelena S. Katanic Stankovic, et al.
Published: (2020-10-01)

Effects of oxaliplatin on mouse myenteric neurons and colonic motility
by: Linah eWafai, et al.
Published: (2013-03-01)

Impact of Dose, Sex, and Strain on Oxaliplatin-Induced Peripheral Neuropathy in Mice
by: Urszula O. Warncke, et al.
Published: (2021-07-01)

Gabapentin and Duloxetine Prevent Oxaliplatin- and Paclitaxel-Induced Peripheral Neuropathy by Inhibiting Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Phosphorylation in Spinal Cords of Mice
by: Natsuki Kato, et al.
Published: (2021-12-01)

The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review
by: Endale Gebreegziabher Gebremedhn, et al.
Published: (2018-04-01)

Differential Transcriptome Profile of Peripheral White Cells to Identify Biomarkers Involved in Oxaliplatin Induced Neuropathy
by: Manuel Morales, et al.
Published: (2014-06-01)

Ameliorative effects of aqueous extract of Forsythiae suspensa fruits on oxaliplatin-induced neurotoxicity in vitro and in vivo
by: Jin-Mu Yi, et al.
Published: (2019-11-01)

The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in patients with coloreactal cancer: study protocol for a single-blinded, randomized sham-controlled trial
by: Kaiyin Chan, et al.
Published: (2020-01-01)

Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors
by: Zhu Yanyun, et al.
Published: (2013-01-01)

Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
by: Yang Li, et al.
Published: (2021-02-01)

Sensorimotor Deficits Following Oxaliplatin Chemotherapy
by: Vincent, Jacob Adam
Published: (2017)

Effect of Vitamin E on oxaliplatin-induced peripheral neuropathy prevention: A randomized controlled trial
by: Zeinab Salehi, et al.
Published: (2015-01-01)

Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy
by: Shota Yamamoto, et al.
Published: (2021-01-01)

Etude des marqueurs de la neuropathie à l’oxaliplatine
by: Delmotte, Jean-Baptiste
Published: (2018)

Increase in spleen volume as a predictor of oxaliplatin toxicity
by: El Chediak A, et al.
Published: (2018-04-01)

The Impact of SBF2 on Taxane-Induced Peripheral Neuropathy
by: Cunningham, Geneva Mari
Published: (2021)

Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants
by: Maho Tsubota, et al.
Published: (2019-10-01)